Ida Enquist

2.6k total citations
13 papers, 674 citations indexed

About

Ida Enquist is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, Ida Enquist has authored 13 papers receiving a total of 674 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Physiology. Recurrent topics in Ida Enquist's work include Cancer Immunotherapy and Biomarkers (7 papers), Lysosomal Storage Disorders Research (5 papers) and Cellular transport and secretion (4 papers). Ida Enquist is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Lysosomal Storage Disorders Research (5 papers) and Cellular transport and secretion (4 papers). Ida Enquist collaborates with scholars based in United States, Japan and Italy. Ida Enquist's co-authors include Mats Ehinger, Jan‐Eric Månsson, Johan Richter, Eva Nilsson, Stefan Karlsson, Roscoe O. Brady, Christophe Lo Bianco, Deniz Kirik, Mark L. McCleland and Jacek Jassem and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Ida Enquist

13 papers receiving 663 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ida Enquist United States 10 312 299 215 203 140 13 674
Sarah Löw Germany 13 27 0.1× 118 0.4× 140 0.7× 152 0.7× 213 1.5× 16 543
Bernhard Heine Germany 13 190 0.6× 149 0.5× 27 0.1× 41 0.2× 243 1.7× 16 565
David Dadey United States 11 42 0.1× 103 0.3× 171 0.8× 55 0.3× 358 2.6× 21 661
M. Victoria Recouvreux United States 11 41 0.1× 155 0.5× 97 0.5× 34 0.2× 363 2.6× 12 655
Anna Chorzalska United States 12 138 0.4× 58 0.2× 78 0.4× 82 0.4× 230 1.6× 40 410
Hai-Su Yang United States 11 81 0.3× 194 0.6× 60 0.3× 35 0.2× 269 1.9× 17 466
Joachim Theilhaber United States 11 116 0.4× 154 0.5× 55 0.3× 17 0.1× 406 2.9× 18 634
Kayo Ijichi Japan 12 21 0.1× 268 0.9× 60 0.3× 234 1.2× 171 1.2× 29 496
Valentina Caprara Italy 14 81 0.3× 118 0.4× 123 0.6× 43 0.2× 349 2.5× 22 523
JulieAnn Rader United States 6 32 0.1× 259 0.9× 58 0.3× 165 0.8× 304 2.2× 8 542

Countries citing papers authored by Ida Enquist

Since Specialization
Citations

This map shows the geographic impact of Ida Enquist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ida Enquist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ida Enquist more than expected).

Fields of papers citing papers by Ida Enquist

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ida Enquist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ida Enquist. The network helps show where Ida Enquist may publish in the future.

Co-authorship network of co-authors of Ida Enquist

This figure shows the co-authorship network connecting the top 25 collaborators of Ida Enquist. A scholar is included among the top collaborators of Ida Enquist based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ida Enquist. Ida Enquist is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Jassem, Jacek, Filippo de Marinis, Giuseppe Giaccone, et al.. (2021). Updated Overall Survival Analysis From IMpower110: Atezolizumab Versus Platinum-Based Chemotherapy in Treatment-Naive Programmed Death-Ligand 1–Selected NSCLC. Journal of Thoracic Oncology. 16(11). 1872–1882. 114 indexed citations
2.
3.
Herbst, Roy S., Filippo de Marinis, Giuseppe Giaccone, et al.. (2021). FP13.03 IMpower110: Updated OS Analysis of Atezolizumab vs Platinum-Based Chemotherapy as First-Line Treatment in PD-L1–Selected NSCLC. Journal of Thoracic Oncology. 16(3). S224–S225. 8 indexed citations
4.
5.
Jassem, Jacek, Roy S. Herbst, Filippo de Marinis, et al.. (2020). IMpower110: Clinical safety in a phase III study of atezolizumab (atezo) monotherapy (mono) vs platinum-based chemotherapy (chemo) in first-line non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology. 38(15_suppl). e21623–e21623. 11 indexed citations
6.
Spigel, David R., Filippo de Marinis, Giuseppe Giaccone, et al.. (2019). IMpower110: Interim overall survival (OS) analysis of a phase III study of atezolizumab (atezo) vs platinum-based chemotherapy (chemo) as first-line (1L) treatment (tx) in PD-L1–selected NSCLC. Annals of Oncology. 30. v915–v915. 112 indexed citations
7.
8.
Enquist, Ida, Zinaida Good, Adrian M. Jubb, et al.. (2014). Lymph node-independent liver metastasis in a model of metastatic colorectal cancer. Nature Communications. 5(1). 3530–3530. 53 indexed citations
9.
Burke, Derek, Rahimin Affandi Abdul Rahim, Simon N. Waddington, et al.. (2012). Increased glucocerebrosidase (GBA) 2 activity in GBA1 deficient mice brains and in Gaucher leucocytes. Journal of Inherited Metabolic Disease. 36(5). 869–872. 24 indexed citations
10.
Farfel‐Becker, Tamar, et al.. (2009). No evidence for activation of the unfolded protein response in neuronopathic models of Gaucher disease. Human Molecular Genetics. 18(8). 1482–1488. 52 indexed citations
11.
Enquist, Ida, Eva Nilsson, Jan‐Eric Månsson, et al.. (2008). Successful Low-Risk Hematopoietic Cell Therapy in a Mouse Model of Type 1 Gaucher Disease. Stem Cells. 27(3). 744–752. 31 indexed citations
12.
Enquist, Ida, Christophe Lo Bianco, Eva Nilsson, et al.. (2007). Murine models of acute neuronopathic Gaucher disease. Proceedings of the National Academy of Sciences. 104(44). 17483–17488. 148 indexed citations
13.
Enquist, Ida, Eva Nilsson, Jan‐Eric Månsson, et al.. (2006). Effective cell and gene therapy in a murine model of Gaucher disease. Proceedings of the National Academy of Sciences. 103(37). 13819–13824. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sarah Löw Breakdown of academic impact, for papers by Bernhard Heine Breakdown of academic impact, for papers by David Dadey Breakdown of academic impact, for papers by M. Victoria Recouvreux Breakdown of academic impact, for papers by Anna Chorzalska Breakdown of academic impact, for papers by Hai-Su Yang Breakdown of academic impact, for papers by Joachim Theilhaber Breakdown of academic impact, for papers by Kayo Ijichi Breakdown of academic impact, for papers by Valentina Caprara Breakdown of academic impact, for papers by JulieAnn Rader
Rankless by CCL
2026